Skip to main content

Infantile myofibrillar myopathy (MFM)

Infantile myofibrillar myopathy (MFM)



Overview

Infantile myofibrillar myopathy (MFM) is a severe, inherited muscle disorder that appears in the first weeks of life, leading to rapid progression of muscle weakness, stiffness, and respiratory failure, often resulting in death within the first six months. It is characterized by the breakdown of muscle fibers (myofibrils) in both skeletal and cardiac muscles, and can also involve heart problems. This condition can be caused by mutations in genes like CRYAB, which provides instructions for making the αB-crystallin protein. 

Symptoms

Early infancy symptoms

Weak crying

Sleep apnea

Recurrent respiratory tract infections

Progressive stiffness of the trunk, abdomen, and limbs 

Other common symptoms

Muscle weakness, especially affecting breathing and movement

Fatigue

Cardiomyopathy (weakened heart muscle), which may be the first symptom

Muscle pain (myalgia)

Loss of sensation in the limbs (peripheral neuropathy)

Skeletal problems like joint stiffness (contractures) or scoliosis (abnormal spine curvature)

Eye problems, such as cataracts 

Causes

Mutations in the CRYAB gene 

Inheritance pattern: It is an autosomal recessive disorder, meaning an affected infant inherits two copies of the mutated CRYAB gene, one from each parent.

Symptoms: The condition typically presents in the first few weeks of life with progressive muscle stiffness (particularly in the trunk and limbs), difficulty breathing, and a poor prognosis with a high risk of early death.

Genetic mechanism: The mutations result in a non-functional or improperly functioning αB-crystallin protein, which is essential for muscle fiber structure. 

Other genetic causes

BAG3-related MFM: In some cases, mutations in the BAG3 gene can also cause an infantile onset of MFM.

DES-related MFM: Mutations in the DES gene can be another cause, with some patients having an infantile disease onset. 

General mechanism of MFM

Z-disk weakening: Regardless of the specific gene involved, MFM is fundamentally caused by a defect in the Z-disk, a crucial part of the muscle fiber.

Protein aggregation: The mutations lead to the accumulation of faulty proteins, weakening the Z-disk and causing the muscle fibers to degenerate over time. 

Diagnosis

Clinical evaluation: A doctor will assess the infant's symptoms, which often include profound muscle weakness, difficulty breathing, and feeding issues.

Electromyography (EMG): This test helps identify non-specific myopathic findings, abnormal electrical activity, and sometimes myotonic discharges.

Muscle biopsy: A muscle biopsy is a key diagnostic tool. It will reveal myofibrillar disorganization, accumulation of abnormal proteins, and a characteristic appearance of deposits in the muscle fibers.

Molecular genetic testing: This can confirm the diagnosis by finding mutations in genes associated with myofibrillar myopathy, such as DES, CRYAB, MYOT, ZASP, FLNC, and others.

Imaging studies:

MRI: A whole-body MRI or Myo-MRI can identify specific patterns of muscle involvement, such as fatty infiltration in certain muscles.

Cardiac screening: Due to the risk of cardiomyopathy, a yearly cardiac screening including electrocardiography (ECG) and echocardiography is recommended. 

Treatment

Symptomatic and supportive treatments

Physical and occupational therapy: These therapies are crucial for maintaining muscle function and independence in daily activities.

Breathing support: If respiratory muscles are weak, support can range from non-invasive methods like CPAP or BiPAP machines to more invasive options like a surgical incision for a breathing tube.

Cardiac management: If the heart muscle is affected, regular monitoring is necessary. Interventions like a pacemaker or ICD may be needed for heart rhythm problems, and in severe cases, a heart transplant could be a consideration. 

Emerging and research-based treatments

Metformin: Studies have shown that the drug metformin can help reduce fiber disintegration and improve muscle function in certain types of myofibrillar myopathy, according to the National Institutes of Health (NIH) and News-Medical.net.

Gene therapy: This is a potential future treatment for some congenital myopathies, though it is still under investigation for myofibrillar myopathy.

Targeted medications: Medications that target calcium and myosin regulation are being explored in research settings. 

Type of Doctor Department : A rheumatologists

Comments

Post a Comment

Popular posts from this blog

Charge Syndrome

Overview CHARGE syndrome is a recognizable genetic syndrome with known pattern of features. It is an extremely complex syndrome, involving extensive medical and physical difficulties that differ from child to child. CHARGE syndrome is correlated with genetic mutation to CHD7 and the prevalence of CHARGE syndrome is 1:10,000-1:15,000 live births. Babies with CHARGE syndrome are often born with life-threatening birth defects. They spend many months in the hospital and undergo many surgeries and other treatments. Swallowing and breathing problems make life difficult even when they come home. Most have hearing two little girls sitting on a carpet, one girl has a trach and is biting her finger.loss, vision loss, and balance problems that delay their development and communication. Despite these seemingly insurmountable obstacles, children with CHARGE syndrome often far surpass their medical, physical, educational, and social expectations. One of the hidden features of CHARGE syndrome is the ...
7 comments
Read more

Dehydration Due to Diarrheal Diseases

Overview Dehydration occurs when you use or lose more fluid than you take in, and your body doesn't have enough water and other fluids to carry out its normal functions. If you don't replace lost fluids, you will get dehydrated. Anyone may become dehydrated, but the condition is especially dangerous for young children and older adults. The most common cause of dehydration in young children is severe diarrhea and vomiting. Older adults naturally have a lower volume of water in their bodies, and may have conditions or take medications that increase the risk of dehydration. This means that even minor illnesses, such as infections affecting the lungs or bladder, can result in dehydration in older adults. Dehydration also can occur in any age group if you don't drink enough water during hot weather — especially if you are exercising vigorously. You can usually reverse mild to moderate dehydration by drinking more fluids, but severe dehydration needs immediate medical treatment. ...
Post a Comment
Read more

Vogt-Koyanagi-Harada (VKH) Disease

  Vogt-Koyanagi-Harada (VKH) Disease Disease Overview Vogt-Koyanagi-Harada disease is a rare disorder of unknown origin that affects many body systems, including as the eyes, ears, skin, and the covering of the brain and spinal cord (the meninges). The most noticeable symptom is a rapid loss of vision. There may also be neurological signs such as severe headache, vertigo, nausea, and drowsiness. Loss of hearing, and loss of hair (alopecia) and skin color may occur along, with whitening (loss of pigmentation) of the hair and eyelashes (poliosis). Signs & Symptoms Vogt-Koyanagi-Harada disease is initially characterized by headaches, very deep pain in the eyes, dizziness (vertigo), and nausea. These symptoms are usually followed in a few weeks by eye inflammation (uveitis) and blurring of vision. This may occur in both eyes at the same time or in one eye first and, a few days later, in the other. The retina may detach and hearing loss may become apparent. The chronic stage follows...
Post a Comment
Read more